← Leaderboards
Hermann Frieboes
University Of Louisville
$3,076,741
Attributed
$5,691,731
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,691,731 · 4
By mechanism
R01$5,229,981 · 3
R15$461,750 · 1
Top collaborators
- Amanda L. Lewis6 shared
- Nicole Marie Gilbert2 shared
Most similar at University Of Louisville
Same institution · by research overlap
- Micah Worley$1,218,000
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventIn VitroAffectFormulationPathogenDesignMouse ModelBacteriaInfectionPre-Clinical ModelProbioticsScaffoldAntibioticsLactobacillusTissuesCellsIn VivoBackEquilibriumFemaleAnaerobic Bacteria3-DimensionalBioprintingDysbiosis
Grant awards (9)
3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis$741,331
R01 · FY2025 · AI · contact PI
3D-bioprinting of probiotic bacterial interference catheters for prevention of catheter-associated urinary tract infections$580,691
R01 · FY2025 · DK
3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis$756,025
R01 · FY2024 · AI · contact PI
3D-bioprinting of probiotic bacterial interference catheters for prevention of catheter-associated urinary tract infections$585,769
R01 · FY2024 · DK
3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis$767,360
R01 · FY2023 · AI · contact PI
Understanding the Host-Microbiome-Therapeutic Triad: Implications for Designing Alternative Intravaginal Delivery Platforms to Treat Bacterial Vaginosis$497,404
R01 · FY2023 · AI · contact PI
3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis$772,879
R01 · FY2022 · AI · contact PI
Understanding the Host-Microbiome-Therapeutic Triad: Implications for Designing Alternative Intravaginal Delivery Platforms to Treat Bacterial Vaginosis$528,522
R01 · FY2022 · AI · contact PI
Integrated framework to predict chemotherapy response post lung tumor resection$461,750
R15 · FY2016 · CA · contact PI